Garcia-Recio, Susana
Hinoue, Toshinori
Wheeler, Gregory L. http://orcid.org/0000-0002-3291-6537
Kelly, Benjamin J.
Garrido-Castro, Ana C. http://orcid.org/0000-0002-5989-6636
Pascual, Tomas
De Cubas, Aguirre A.
Xia, Youli
Felsheim, Brooke M. http://orcid.org/0000-0001-8421-8290
McClure, Marni B.
Rajkovic, Andrei
Karaesmen, Ezgi
Smith, Markia A. http://orcid.org/0000-0002-7114-3776
Fan, Cheng
Ericsson, Paula I. Gonzalez http://orcid.org/0000-0002-6292-6963
Sanders, Melinda E.
Creighton, Chad J. http://orcid.org/0000-0002-6090-703X
Bowen, Jay http://orcid.org/0000-0001-6861-9043
Leraas, Kristen
Burns, Robyn T.
Coppens, Sara
Wheless, Amy
Rezk, Salma
Garrett, Amy L.
Parker, Joel S. http://orcid.org/0000-0003-2080-6901
Foy, Kelly K.
Shen, Hui
Park, Ben H.
Krop, Ian
Anders, Carey http://orcid.org/0000-0001-9165-4074
Gastier-Foster, Julie
Rimawi, Mothaffar F. http://orcid.org/0000-0002-4284-5656
Nanda, Rita http://orcid.org/0000-0001-5248-0876
Lin, Nancy U.
Isaacs, Claudine
Marcom, P. Kelly
Storniolo, Anna Maria
Couch, Fergus J.
Chandran, Uma
Davis, Michael
Silverstein, Jonathan http://orcid.org/0000-0002-9252-6039
Ropelewski, Alexander http://orcid.org/0000-0001-6874-4477
Liu, Minetta C. http://orcid.org/0000-0002-8206-5232
Hilsenbeck, Susan G.
Norton, Larry
Richardson, Andrea L.
Symmans, W. Fraser http://orcid.org/0000-0002-1526-184X
Wolff, Antonio C.
Davidson, Nancy E.
Carey, Lisa A. http://orcid.org/0000-0003-2388-4649
Lee, Adrian V. http://orcid.org/0000-0001-9917-514X
Balko, Justin M. http://orcid.org/0000-0002-4263-5974
Hoadley, Katherine A. http://orcid.org/0000-0002-1216-477X
Laird, Peter W. http://orcid.org/0000-0001-9117-3641
Mardis, Elaine R. http://orcid.org/0000-0002-5892-1553
King, Tari A.
De Cubas, Aguirre A.
Perou, Charles M. http://orcid.org/0000-0001-9827-2247
,
Article History
Received: 5 July 2022
Accepted: 11 November 2022
First Online: 30 December 2022
Competing interests
: The following authors disclose conflicts of interest. C.M.P. is listed as an inventor on patent applications on the Breast PAM50 assay and is an equity stock holder and consultant of BioClassifier LLC. J.S.P. is listed as an inventor on patent applications on the Breast PAM50 assay. H.S. has authorship and equity in AnchorDX, authorship with Illumina and an IP license with TruDiagnostics, Inc. B.H.P. has royalties: Horizon Discovery, Ltd.; Consultant: EQRx, Sermonix, Hologics, Jackson Laboratories, Guardant Health Inc; Unpaid consultant: Tempus; Consultant and ownership interest: Celcuity; Research Contracts: GE Healthcare, Lilly and Pfizer. I.K. has: Consulting Fees (e.g. advisory boards); Author; Bristol Meyers Squibb, Daiichi/Sankyo, Macrogenics, Context Therapeutics, Taiho Oncology, Genentech/Roche, Seattle Genetics. Contracted Research; Author; Genentech/Roche, Pfizer. Other; Author; Novartis, Merck (DSMB member). C.A. has: Research funding: Puma, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1 Therapeutics, ZION, Novartis, Pfizer; Compensated consultant role: Genentech, Eisai, IPSEN, Seattle Genetics, AstraZeneca, Novartis, Immunomedics, Elucida, Athenex; Royalties: UpToDate, Jones and Bartlet. M.F.R. has: Consulting Fees (e.g. advisory boards); Author; Macrogenics, Daiichi, and Genentech. Contracted Research; Author; Pfizer. R.N. is an author with Aduro, AstraZeneca, Athenex, Celgene, Daiichi Sankyo, Inc., Genentech, MacroGenics, Merck, Novartis, Pfizer, Puma, Syndax. Contracted Research; Author; AstraZeneca, Celgene, Concept Therapeutics, Genentech/Roche, Immunomedics, Merck, Odonate Therapeutics, Pfizer, Seattle Genetics. Other; Author; DSMB:G1 Therapeutics; Steering Committee: OBI Pharm, Inc. N.U.L. has: Consulting Fees (e.g. advisory boards); Author; Seattle genetics, Puma and Daichii. Contracted Research; Author; Genentech, Seattle Genetics, Pfizer. C.I. has Consulting Fees (e.g. advisory boards); Author; Pfizer, AstraZeneca, Genentech, Novartis, Puma, Seattle Genetics, Sanofi, Eisai, Biotheranostics, and Gilead. Royalties; Author Wolters Kluwer (UpToDate), McGraw Hill (Goodman and Gilman’s); Research funding (to institution) Merck, Seattle Genetics, Pfizer, GlaxoSmithKline. M.C.L. has: Author; Eisai, Genentech, GRAIL, Janssen, Merck, Novartis, Seattle Genetics, Tesaro. J.M.B. has: Receipt of Intellectual Property Rights / Patent Holder; Author; Provisional patents regarding immunotherapy targets and biomarkers in cancer. Consulting Fees (e.g. advisory boards); Author; Novartis. Contracted Research; Author; Genentech/Roche, Bristol Myers Squibb, and Incyte Corporation. P.W.L. has: Consulting Fees (e.g. advisory boards); Progenity, Inc., Stock Options; Author; AnchorDx, Author: Progenity, Inc.Illumina, Inc., IP License; TruDiagnostic Inc. A.C.G.-C.: Research funding (to Institution) from Merck, Gilead Sciences, and AstraZeneca. All remaining authors have no relevant disclosures.